Current Report Filing (8-k)
26 October 2016 - 7:07AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
October 25, 2016
SECOND SIGHT MEDICAL PRODUCTS, INC.
|
(Exact Name of Registrant as Specified in Its Charter)
|
|
California
|
(State or Other Jurisdiction of Incorporation)
|
333-198073
|
|
02-0692322
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
12744 San Fernando Road, Suite 400
Sylmar, California 91342
|
(Address of Principal Executive Offices)
|
(818) 833-5000
|
(Registrant's Telephone Number, Including Area Code)
|
|
|
(Former Name or Former Address, if Changed Since Last Report)
|
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 7.01
.
REGULATION
FD DISCLOSURE
A copy of a slide presentation
that Second Sight Medical Products, Inc. ("Second Sight ") intends to use during presentations made before groups and
in hosting one-on-one meetings with individuals at the at the MicroCap Conference being held on October 25, 2016, at the Hotel
Monaco in Philadelphia (the "Presentation Materials"), is attached to this Current Report on Form 8-K as Exhibit 99.1
and is incorporated by reference herein.
The Presentation Materials speak as of the
date of this Current Report on Form 8-K. While
Second Sight
may elect to
update the Presentation Materials in the future or reflect events and circumstances occurring or existing after the date of this
Current Report on Form 8-K,
Second Sight
specifically disclaims any obligation
to do so.
The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth
by reference in such a filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
Exhibit No. Description
99.1 Second Sight Medical Products, Inc.
Investor Presentation dated October 2016
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 25, 2016
SECOND SIGHT MEDICAL PRODUCTS, INC.
|
|
|
|
/s/ Thomas B. Miller
|
|
By: Thomas B. Miller
|
|
Chief Financial Officer
|
|
Second Sight Medical Pro... (NASDAQ:EYES)
Historical Stock Chart
From Apr 2024 to May 2024
Second Sight Medical Pro... (NASDAQ:EYES)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Second Sight Medical Products Inc (NASDAQ): 0 recent articles
More Second Sight Medical Products Inc News Articles